Sorrento Therapeutics Inc (SRNE): Sorrento's cancer portfolio is outst...

Reply Private New

Next 10 Prev Next

Send PM Follow Ignore

Followers	57
Posts	5700
Boards Moderated	0
Alias Born	12/13/2004

dia76ca

Re: Jesspro post# 12438

Sunday, 01/02/2022 1:57:34 PM

Sunday, January 02, 2022 1:57:34 PM

Sorrento's cancer portfolio is outstanding.
1. ABIVERTINIB(3rd gen.BTK) multi-billion potential in a dozen cancers
2. ADNAB(Mayo Clinic) in a dozen cancers
3. CAR-T's and ADC's in a dozen cancers
4. DAR-T in a dozen cancers
5. second generation Oncolytic virus in a dozen cancers

"The refusal of the real is the number one dogma of our time" Rene Girard

Keep Last Read

Next 10 Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

Detailed Quote

Recent SRNE News

Form 8-K - Current report • Edgar (US Regulatory) • 11/03/2023 09:31:06 PM
Form 8-K - Current report • Edgar (US Regulatory) • 10/27/2023 08:15:31 PM
Form 8-K - Current report • Edgar (US Regulatory) • 09/13/2023 01:51:06 AM
Form 8-K - Current report • Edgar (US Regulatory) • 08/28/2023 09:25:07 PM
Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 08/07/2023 08:15:35 PM
Form 8-K - Current report • Edgar (US Regulatory) • 08/01/2023 10:01:54 AM
Form 8-K - Current report • Edgar (US Regulatory) • 07/13/2023 10:26:26 AM